Preface. Learning to operate a flow cytometer is best achieved by using the instrument. However This document contains basic information on flow cytometry. Flow Cytometry Basics Guide | 3. 1 Principles of the. Flow Cytometer. Fluidics System. One of the fundamentals of flow cytometry is the ability to measure the. flow cytometry such as immunophenotyping of peripheral blood cells, analysis of underlying principle of flow cytometry is related to light.
|Language:||English, Japanese, Arabic|
|ePub File Size:||23.51 MB|
|PDF File Size:||9.76 MB|
|Distribution:||Free* [*Sign up for free]|
The flow cytometer was developed in the 's and rapidly be- came an essential instrument for the biologic sciences. Spurred by the HIV pandemic and a. sub-populations. The cells were investigated using a BD FACScan flow cytometer. . bestthing.info While such plots. Flow Cytometry is a widely used method for cell analysis which, for the novice With respect to cellular analysis, the underlying principle of flow cytometry is that .
The collection process starts when a sample is injected into a stream of sheath fluid that passes through the flow cell and laser intercepts. The disturbance in the stream causes it to break into a droplet containing ideally one cell. An electrical charging ring is placed just at the point where the stream breaks into droplets.
A charge is placed on the ring based immediately prior to fluorescence intensity being measured, and the opposite charge is trapped on the droplet as it breaks from the stream. The charged droplets then fall through an electrostatic deflection system that diverts droplets into containers based upon their charge.
In some systems, the charge is applied directly to the stream, and the droplet breaking off retains charge of the same sign as the stream. The stream is then returned to neutral after the droplet breaks off. If collected under sterile conditions, these cells can be further cultured, manipulated, and studied. Labels[ edit ] Use of flow cytometry to measure copy number variation of a specific DNA sequence Flow-FISH Flow cytometry uses the light properties scattered from cells or particles for identification or quantitative measurement of physical properties.
Labels, dyes, and stains can be used for multi-parametric analysis understand more properties about a cell. Immunophenotyping is the analysis of heterogeneous populations of cells using labeled antibodies  and other fluorophore containing reagents such as dyes and stains.
New advances in microfluidic flow cytometry
Main article: Fluorophore A wide range of fluorophores can be used as labels in flow cytometry. In clinical practice and in research settings, cellular evaluation by imaging technologies and flow cytometry provides significant information reflecting the particular cellular phenotype, both normal and pathological. Microscopy provides a wealth of information, but data acquisition rates are slow and analysis is generally subjective.
In flow cytometry, data acquisition is rapid and better suited for the evaluation of pathologies present in low frequency, but the data are only intensity-based, thus lacking the morphology that truly lends credence to the analysis.
In addition, the assessment and evaluation of cell samples by imaging and flow cytometric techniques is complicated by a number of factors. For instance, changes in a cell type or phenotypic changes in a cell subpopulation often occur in heterogeneous cell mixtures; there is phenotypic variability amongst populations, especially in human clinical settings; and the cell population of interest may be present in a very low frequency.
The relative benefits of technologies to evaluate cells and cell populations will be discussed in this context. Comparisons of Technologies Every form of cytologic instrumentation represents a compromise. As a general rule, there's a tradeoff between acquisition speed, fluorescence sensitivity, and information content. For example, a confocal microscope can produce highly detailed fluorescent cell images, including three dimensional cell representations based on multiple stacked images, but it can take as long as several minutes to produce a high resolution 3D representation of a single cell.
Absolute fluorescence sensitivity is also generally lower in confocal microscopy than other techniques because out-of-focus signals are rejected by the confocal optical system and because the image is built up serially from individual measurements at every location across the cell, reducing the amount of time available to collect signal.
Sensitivity may be increased in a single image by dwelling over the cell for a longer period of time, but this can cause excessive photobleaching outside of the plane of focus, hindering 3D imaging. The design features associated with confocal microscopy make it well-suited to applications that require the accurate analysis of sub-cellular features in homogeneous samples, but poorly suited to detecting faint fluorescent probes or evaluating statistically significant numbers of cells within heterogeneous samples.
Although high resolution, 3D representations of cells by confocal imaging may be useful in certain areas of clinical research, confocal imaging is not widely used in clinical assessment or diagnostics.
The most obvious difference between the techniques is that flow cytometry requires cells to be in suspension rather than on slides. Further, flow cytometry sacrifices imaging entirely in favor of high acquisition rates and fluorescence sensitivity. In flow cytometry, each detection event cell is associated with several numerical measurements of fluorescence intensity and the degree of forward and side scatter of laser light.
Forward scatter is roughly correlated to the size of the cell and side scatter gives an indication of the cell's granularity, but flow cytometry offers no means of sub-cellular fluorescence localization. The strength of flow cytometry is that it allows the rapid analysis of large populations of cells. Typical analytical throughput is 5, cells per second, which means that even rare cell populations i.
Fluorescence detection limits are often less than molecules per cell. The combination of high speed and high quantitative fluorescence sensitivity makes the technique well-suited, for situations such as ectopic expression of ZAP in CLL, which is a prognostic indicator. In contrast to confocal microscopy, standard microscopy can image cells in a variety of modes transmitted light, scattered light, fluorescence, phase contrast, etc. As gene sequences are revelaed, efficient methodologies to functionally characterize these genes in vivo are needed.
A novel drug discovery approach has used retroviral vectors in which combinatorial oligonucleotide inserts create intracellularly expressed peptides. With one vector per cell, each cell becomes an assay for the peptide encoded by that insert Sorting cells with the desired phenotype, and sequencing the insert, can reveal novel regulatory pathways. When the library involves genomic inserts, the assays for the insert can reflect novel pathways of protein-protein interaction The sorting capabilities of flow cytometry have been extended from the 1—10 micron size range into the millimeter size range http: Sorting rates for millimeter sized particles are typically reduced two orders of magnitude from the speeds achieved for micron sized particles.
These new capabilities are adding to the utility of flow cytometry for analysis of chemical and biological diversity. For chemical diversity, combinatorial libraries of small molecules can be displayed on microspheres 40 of sufficient size that the active molecules can be identified by mass spectrometry. These particles, in a one-bead one-compound OBOC format, can be used in conjunction with binding of fluorescence ligands, or receptors, as well as in cell-based applications to detect chemical species which interact with the desired target.
In biological diversity, the new sorting technology may enable the analysis and sorting of small multicellular animals such as C.
These capabilities would amplify the power of flow cytometry for the secondary screening of more complex biological systems. Flow cytometry has traditionally been used for the analysis of individual samples. However, flow cytometers have now been coupled to a variety of input systems. For example, automation of delivery systems of flow cytometers is leading to their use with bioreactors that can be monitored continually 42 , 43 , with multwell plates see below , with subsecond reaction kinetics 10 , and with devices that produce shear forces on cells or cell aggregates to model the environment of flowing blood 44 , This bottleneck precludes the screening of large compound collections.
We have described successive generations of sample handling technology to address this issue. The second uses a peristaltic pump in combination with an autosampler to boost assay throughput 47 , As the sampling probe of the autosampler moves from well to well, a peristaltic pump sequentially aspirates particle suspensions from each well.
Between wells, the running pump draws a bubble of air into the sample line resulting in the devliery of a series of bubble-separated samples.
This system has been validated for cell-based high throughput endpoint assays for ligand binding, surface antigen expression, and immunophenotyping. The particle counting ability of flow cytometry can be adapted for high throughput analysis of compound solubility.
The data from all wells of a microplate is collected in a single data file. The time-resolved data, with periodic gaps corresponding to the passage of the sample-separating air bubbles, are analyzed by software. Flow cytometry has been successfully used for small molecule discovery for GPCR 49 — 51 with fluorescent ligand and cell based approaches.
Multiplex data sets are beginning to be generated. The NIH Roadmap aims to accelerate biomedical research and create new tools for discovery. The MLI is focused on chemical biology and consists of initiatives for individual investigators and centers to discover small molecules useful as biological probes, imaging agents, and potentially as leads for drug discovery.
The centers identify active molecules and chemically optimize those molecules for biological activity. First, through outreach, we are collaboratively developing biological targets for screening See Table 2 , allowing the technology to be shared with the discovery community. Second, we are exploring unique features of flow cytometry for high content and multiplex screening intended to permit the determination of small molecule selectivity and specificity in a single step.
The grant number in Table 2 can be used to track the screening progress and to locate descriptions of the target proposal and the assay. Automation of the HT flow cytometric platform is in process the NM MLSC with a goal of delivering five well plates to a flow cytometer every hour, with 10 parameter or plex assays.
We project that the HT platform, with modifications to the fluidics system, is compatible with sampling in well plates at the same rate as for well plates. We also view the application of flow cytometry to SiRNA libraries as a significant future opportunity. Flow cytometry provides a unique set of capabilities for the analysis of cells and particles with a wide range of applications that include molecular assembly and receptor pharmacology, high content analysis of signaling pathways and images, multiplexing of biological targets, sorting of large particles and small organisms, and plate based analysis for screening and discovery.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
National Center for Biotechnology Information , U. Curr Opin Pharmacol. Author manuscript; available in PMC Oct 1. Larry A. Sklar , Mark B. Carter , and Bruce S. Author information Copyright and License information Disclaimer. Copyright notice. The publisher's final edited version of this article is available at Curr Opin Pharmacol.
See other articles in PMC that cite the published article. Summary While flow cytometry is viewed as a mature technology, there have been dramatic advances in analysis capabilities, sorting, sample handling and sensitivity in the last decade.
Introduction The modern flow cytometer analyzes and sorts cells or particles at rates up to 50, per second. Diversity of biological targets Flow cytometry is compatible with large numbers of biological assays and targets. Molecular Assembly Flow cytometry allows homogeneous detection of molecular assembly, analysis of binding affinity, subsecond resolution of binding kinetics, often with femtomole sensitivity 9 — High Content Flow cytometry provides opportunities for multiplexing 19 and high content analysis that includes pixel by pixel imaging 3 , High Content Analysis of Phosphoprotein Networks Phosphoprotein profiling is a mainstay of bead-based multiplexing where phosphoproteins from cell lysates are first captured by an antibody on a bead and then quantified by a second antibody.
Image Flow Cytometry High content analysis has been extended to an image analysis flow cytometer that combines CCD technologies and an optical architecture for high sensitivity and multispectral imaging of cells 3 , 20 , Sorting Speed and Particle Size Flow cytometry sorts cell populations with the desired phenotype.
Sample Handling and Automation Flow cytometry has traditionally been used for the analysis of individual samples. Open in a separate window. Summary Flow cytometry provides a unique set of capabilities for the analysis of cells and particles with a wide range of applications that include molecular assembly and receptor pharmacology, high content analysis of signaling pathways and images, multiplexing of biological targets, sorting of large particles and small organisms, and plate based analysis for screening and discovery.
Footnotes Publisher's Disclaimer: Sklar LA, editor. Flow Cytometry for Biotechnology. Oxford University Press; Herzenberg LA, et al.
The history and future of the fluorescence activated cell sorter and flow cytometry: Bonetta L. Flow Cytometry, Smaller and Better. Nature Methods. Robinson JP. Flow Cytometry.
Encyclopedia of Biomaterials and Biomedical Engineering. Marcel Dekker Inc. Robinson J Paul. Current Protocols in Cytometry. Wiley Intescience; http: Flow Cytometry: A versatile tool for all phases of Drug Discovery. Drug Discovery Today. Shapiro Howard M. Fluorescent Probes. Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor.
Clin Cancer Res. The emergence of flow cytometry for the sensitive, real-time analysis of molecular assembly. Nature Biotechnology.
Flow Cytometry for analysis of membrane ligand-receptor interactions and macromolecular assembly.Methods Mol Biol. Cell-based assays evaluated the effects of the novel protein kinase C PKC inhibitor enzastaurin on intracellular phosphoprotein signaling 8 in blood obtained from patients before and after receiving daily oral doses of enzastaurin.
Carter , and Bruce S. The centers identify active molecules and chemically optimize those molecules for biological activity. For instance, dysplastic and neoplastic cells have been detected in lung sputum on the basis of morphology.